COMMUNIQUÉS West-GlobeNewswire

OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations
27/10/2026
New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction WARSAW, Ind., Oct. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the " [...]
PacBio to Participate in Upcoming Investor Conferences
27/10/2026
MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the [...]
OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance
27/10/2026
Record Third Quarter 2026 Revenue of $72.7 Million , Up 19% Year-over-Year WARSAW, Ind., Oct. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused [...]
Adlai Nortye Announces Oral Presentation for AN4035 Program Update at the Upcoming 38th EORTC-NCI-AACR Symposium
27/10/2026
AN4035 late-breaking abstract selected for an oral presentation at the upcoming ENA Symposium in Barcelona Oral presentation will include translational and EGFR combination data for first-in-class AN4035 AN4035 is a [...]
Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer
27/10/2026
Seasoned oncology executive brings extensive clinical development expertise and a track record of advancing innovative cancer therapies SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF [...]
Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
27/10/2026
NOVATO, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra- [...]
Bionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026
27/10/2026
SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, November 10, 2026, at 4:30 p.m. Eastern Time to report [...]
Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
27/10/2026
IRVINE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter [...]
Ligand to Participate in November Investor Conferences
27/10/2026
JUPITER, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: UBS [...]
Arvinas Announces Return of Early Career Researcher Award to Recognize Innovation in Targeted Protein Degradation
27/10/2026
– $25,000 monetary award to recognize an emerging researcher or research team advancing targeted protein degradation – – Nominations open November 1, 2026, and close December 31, 2026; winner to be recognized in mid- [...]
Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation
27/10/2026
Company to host an in-person and virtual Investor Day on November 12, 2026 BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system ( [...]
Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
27/10/2026
WALTHAM, Mass. and BOULDER, Colo., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today [...]
Arcutis Management to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
27/10/2026
WESTLAKE VILLAGE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
What Happens During a Dental Implant Consultation in Tukwila
27/10/2026
Candidacy for implants and All-on-X full-arch treatment is evaluated in a single visit, with 3D imaging and digital impressions done in-house. Implants are placed and restored by the same dentist at South Seattle Smiles [...]
Eurobio Scientific: communiqué relatif au dépôt de la note en réponse
27/10/2026
COMMUNIQUÉ DU 27 OCTOBRE 2026 RELATIF AU DÉPÔT DU PROJET DE NOTE D’INFORMATION ÉTABLI PAR LA SOCIÉTÉ EUROBIO SCIENTIFIC EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS [...]
EB Development : communiqué relatif au dépôt de l'offre modifiée
27/10/2026
COMMUNIQUÉ DU 27 OCTOBRE 2026 RELATIF AU DÉPÔT D’UNE OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC Pièce jointe 03. EB Development - Communiqué normé - [...]
Venus Williams Reveals Her Secret for What Women Fear Most
27/10/2026
Tennis Legend’s Breast Cancer Prevention PSA Receives Millions of Views in AMC Theaters WASHINGTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Tennis legend Venus Williams has revealed in a new video message her strategy for one [...]
Lenny Peters Cup Turns High Point, N.C., Into an International Rowing Destination
27/10/2026
Dutch Olympic champions defeat Team USA, while visitors, hotel bookings and local spending highlight the impact of sports philanthropy High Point, NC, Oct. 27, 2026 (GLOBE NEWSWIRE) -- What began as a regatta with two [...]
Beeline Medicines to Present Results from the Phase 2 Trial of Afimetoran in Systemic Lupus Erythematosus as a Late-Breaking Oral Presentation at ACR Convergence 2026
27/10/2026
– Results demonstrate consistent improvements across measures of disease activity, quality of life, and pharmacodynamic markers, with a tolerable safety profile across all afimetoran dose groups – – Safety and efficacy [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum